Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial macromolecules, including proteins, DNA, and RNA, represent the collective target for antimicrobial agents that exert their effects through the release of formaldehyde (DrugBank Online, DB00571). Formaldehyde acts as a non-specific, highly reactive electrophile that induces chemical damage by forming methylene bridges between nucleophilic groups, such as amines and thiols (PubChem, CID 712). This process results in extensive cross-linking of cellular components, which denatures essential enzymes, disrupts the bacterial cell wall, and causes irreversible damage to the genetic material (StatPearls, Methenamine, 2023). Due to the multi-targeted and non-specific nature of this chemical damage, the development of bacterial resistance is significantly less likely compared to site-specific antibiotics (Journal of Antimicrobial Chemotherapy, 2002). This target is primarily exploited in clinical practice by the prodrug methenamine, which is used for the prophylaxis and treatment of urinary tract infections by generating formaldehyde in the acidic environment of the bladder (StatPearls, Methenamine, 2023). Other agents, such as taurolidine, also utilize this mechanism for antiseptic purposes in various clinical settings (PubMed, PMID 3310155).
Formaldehyde-mediated cross-linking of proteins and nucleic acids (methylene bridge formation), leading to non-specific denaturation and bacterial cell death.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial macromolecule.